ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
42 announcements with these filters
Q2 revenue rose 27.5% to ₹549.2 Cr and net loss narrowed to ₹15.2 Cr. Chemicals drove gains; sugar-ethanol remains loss-making and seasonal.
Q2 FY27 consolidated revenue ₹549.2 Cr (+27% YoY) and EBITDA ₹10.9 Cr (2.0% margin) turned positive; PAT loss ₹15.2 Cr. Bio-based chemicals drive growth; sugar/ethanol remains loss-making.
Q2 FY27 revenue rose 26.6% YoY to Rs.549.8 Crore, with EBITDA turning positive. Net loss narrowed to Rs.15.2 Crore from Rs.41.6 Crore a year earlier.
Godavari Biorefineries Ltd reported revenue from operations of ₹549.2 Cr (+27.5% YoY) and a net loss of ₹15.2 Cr for Q2 FY27.
Godavari Biorefineries has given prior intimation of a board meeting on 4 November 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window stays closed from 1 October until 48 hours after results.
Godavari Biorefineries Ltd has submitted its quarterly shareholding pattern as per SEBI regulations. This is a routine regulatory compliance filing.
Godavari Biorefineries Ltd has been granted a US patent for a compound targeting cancer treatment. This patent covers a novel class of cancer-inhibiting compounds.
Godavari Biorefineries Ltd submitted a compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, for the quarter ended 30th September, 2026.
Godavari Biorefineries Limited has been granted a patent by the Mexican Patent Office for its invention concerning compounds for treating viral infections.
Godavari Biorefineries announced the re-appointment of Directors and MD, along with the appointment of Mr. Dinesh Sharma as a whole-time director.
Godavari Biorefineries Ltd held its 71st Annual General Meeting on September 28, 2026. The meeting covered routine items like financial statements, director appointments, and remuneration approvals.
Godavari Biorefineries received a Rs. 12.88 Crore demand notice from HESCOM for cross-subsidy charges on power imported between 2013-2016. The company is assessing the liability.
China's patent office granted Godavari Biorefineries a patent for compounds treating viral infections. The invention covers V-ATPase inhibition for medicament use.
Godavari Biorefineries Ltd has been granted a patent by the European Patent Office for its 'A Biofiller for Rubber Reinforcement' technology.
Godavari Biorefineries Limited submitted its 2025-26 Annual Report, prior to the 71st Annual General Meeting scheduled for September 28, 2026.
Godavari Biorefineries Ltd issued the notice for its 71st Annual General Meeting, scheduled for September 28, 2026, via video conferencing.
Godavari Biorefineries Ltd received a show-cause notice from the Karnataka Commercial Tax Department for GST-related short payments totaling approximately ₹18.13 Crore.
Godavari Biorefineries received a GST show-cause notice of ₹17.02 Crore for the period 2021-2024. The company is evaluating the claim and preparing its legal response.
Q1 FY27 revenue grew 4.6% to ₹557.9 Cr, but EBITDA fell to ₹2.6 Cr. Performance was pressured by high inventory costs and raw material prices despite strong chemical segment growth.
Godavari Biorefineries received a European patent for an anti-cancer pharmaceutical composition. This grant strengthens the company's oncology-focused intellectual property portfolio and therapeutic potential.
Godavari Biorefineries reported Q1 FY27 total income of ₹559.9 Cr, up 4.9% YoY. Strategy focuses on bio-based chemicals and ethanol capacity expansion.
Godavari Biorefineries released its Q1 FY27 financial results. The company successfully commissioned a new 200 KLPD grain-based distillery in Sameerwadi, enhancing total ethanol capacity.
Godavari Biorefineries Ltd reported revenue from operations of ₹557.9 Cr (+4.6% YoY) and a net loss of ₹19.3 Cr for Q1 FY27.
Godavari Biorefineries Ltd scheduled a board meeting for August 5, 2026, to consider and approve the un-audited financial results for the quarter ended June 30, 2026.
Godavari Biorefineries Ltd has submitted its quarterly shareholding pattern for the period ended June 30, 2026. This filing discloses the distribution of shareholding among various investor categories.
Godavari Biorefineries re-appointed Nitin Mehta as Independent Director and Sangeeta Srivastava as Whole Time Director. These appointments follow shareholder approval via postal ballot.
Godavari Biorefineries is investing Rs.130 Crore to add 200 KLPD distillery capacity. The expansion provides dual-feedstock capability to meet rising ethanol blending demand.
Godavari Biorefineries Ltd announced the voting results of its postal ballot. Shareholders approved the re-appointment of Mr. Nitin Mehta and Dr. Sangeeta Srivastava.
Godavari Biorefineries commenced operations at its Sameerwadi corn-based distillery. The project involved a ₹130 Crore investment with 200 KLPD capacity.
Godavari Biorefineries Ltd announced that the Japanese Patent Office granted its patent “5‑HYDROXY‑1,4‑NAPHTHALENEDIONE for use in cancer treatment.” The grant enhances the company’s IP portfolio for oncology therapeutics.